Aspire Private Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $362K | Sell |
2,819
-658
| -19% | -$77K | 0.07% | 135 |
|
|
2026
Q1 | $418K | Buy |
3,477
+536
| +18% | +$61.9K | 0.09% | 130 |
|
|
2025
Q4 | $310K | Sell |
2,941
-36
| -1% | -$3.38K | 0.07% | 139 |
|
|
2025
Q3 | $250K | Sell |
2,977
-1,085
| -27% | -$89.4K | 0.05% | 163 |
|
|
2025
Q2 | $322K | Sell |
4,062
-837
| -17% | -$66.5K | 0.07% | 153 |
|
|
2025
Q1 | $440K | Sell |
4,899
-8,097
| -62% | -$756K | 0.11% | 134 |
|
|
2024
Q4 | $1.29M | Buy |
12,996
+1
| +0% | +$103 | 0.32% | 60 |
|
|
2024
Q3 | $1.48M | Buy |
12,995
+962
| +8% | +$114K | 0.35% | 54 |
|
|
2024
Q2 | $1.49M | Buy |
12,033
+833
| +7% | +$107K | 0.38% | 48 |
|
|
2024
Q1 | $1.48M | Buy |
11,200
+1,321
| +13% | +$163K | 0.39% | 43 |
|
|
2023
Q4 | $1.08M | Buy |
9,879
+302
| +3% | +$31.3K | 0.32% | 45 |
|
|
2023
Q3 | $986K | Buy |
9,577
+379
| +4% | +$40.9K | 0.32% | 40 |
|
|
2023
Q2 | $1.06M | Sell |
9,198
-810
| -8% | -$92K | 0.34% | 42 |
|
|
2023
Q1 | $1.06M | Sell |
10,008
-44
| -0.4% | -$4.75K | 0.35% | 42 |
|
|
2022
Q4 | $1.12M | Buy |
10,052
+545
| +6% | +$55.7K | 0.4% | 39 |
|
|
2022
Q3 | $819K | Sell |
9,507
-143
| -1% | -$12.8K | 0.31% | 44 |
|
|
2022
Q2 | $880K | Sell |
9,650
-804
| -8% | -$71.3K | 0.31% | 43 |
|
|
2022
Q1 | $858K | Buy |
10,454
+2,216
| +27% | +$175K | 0.27% | 44 |
|
|
2021
Q4 | $631K | Buy |
8,238
+6,045
| +276% | +$481K | 0.2% | 71 |
|
|
2021
Q3 | $165K | Buy |
2,193
+73
| +3% | +$5.55K | 0.06% | 145 |
|
|
2021
Q2 | $165K | Sell |
2,120
-1,726
| -45% | -$128K | 0.05% | 150 |
|
|
2021
Q1 | $283K | Sell |
3,846
-3,898
| -50% | -$288K | 0.1% | 121 |
|
|
2020
Q4 | $604K | Buy |
7,744
+1,693
| +28% | +$129K | 0.23% | 66 |
|
|
2020
Q3 | $479K | Buy |
6,051
+959
| +19% | +$75.1K | 0.2% | 72 |
|
|
2020
Q2 | $379K | Buy |
5,092
+1,458
| +40% | +$110K | 0.18% | 75 |
|
|
2020
Q1 | $267K | Buy |
3,634
+1,704
| +88% | +$134K | 0.14% | 78 |
|
|
2019
Q4 | $168K | Buy |
1,930
+29
| +2% | +$2.38K | 0.07% | 121 |
|
|
2019
Q3 | $153K | Buy |
1,901
+117
| +7% | +$9.38K | 0.07% | 119 |
|
|
2019
Q2 | $143K | Buy |
1,784
+178
| +11% | +$13.6K | 0.07% | 129 |
|
|
2019
Q1 | $127K | Buy |
1,606
+849
| +112% | +$63.5K | 0.06% | 153 |
|
|
2018
Q4 | $55K | Buy |
+757
| New | +$53.4K | 0.03% | 207 |
|
Other funds holding MRK
Aspire Private Capital's MRK Position: Q2 2026 in Review
Aspire Private Capital reduced its Merck (MRK) stake by 19% in Q2 2026, selling an estimated $77K and leaving 2,819 shares worth $362K. The position accounts for 0.07% of the portfolio, ranked #135.
Aspire Private Capital first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.49M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Aspire Private Capital held 2,819 shares of Merck worth $362K as of Q2 2026.
- Aspire Private Capital sold 658 Merck shares in Q2 2026, an estimated $77K.
- Merck made up 0.07% of Aspire Private Capital's portfolio in Q2 2026, its #135 holding.
- Aspire Private Capital first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Aspire Private Capital's Merck position peaked at $1.49M in Q2 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Aspire Private Capital's 13F filing for Q2 2026, filed 15 Jul 2026.